Virtus ETF Advisers’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Virtus ETF Advisers's EDIT Position: Q4 2024 in Review
Virtus ETF Advisers sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 16,790 shares — an estimated $57.3K sold.
Virtus ETF Advisers first reported a position in EDIT in Q2 2020 and held it in 18 quarters. The position peaked at $384K in Q2 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.
- Virtus ETF Advisers reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
- Virtus ETF Advisers sold 16,790 Editas Medicine shares in Q4 2024, an estimated $57.3K.
- Virtus ETF Advisers first reported a position in Editas Medicine in Q2 2020 and held it in 18 quarters.
- Virtus ETF Advisers's Editas Medicine position peaked at $384K in Q2 2020.
- 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.
Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.